Latest Aegis Therapeutics LLC Stories

2008-11-12 15:00:26

Aegis Therapeutics LLC announced today that preclinical data was presented at the 2008 International Congress of Endocrinology in Rio de Janeiro, Brasil demonstrating that its Intravail(R) formulation technology provides unmatched non-invasive delivery of the OB-3 peptide, a peptide previously shown to control weight gain and glucose levels in an animal model of diabetes. The results of the study, presented by Dr. Patricia Grasso, Associate Professor in the Department of Medicine and Center...

2008-10-01 15:00:50

Reportlinker.com announces that a new market research report related to the Pharmaceutical industry industry is available in its catalogue. World Intranasal Drug Delivery Market http://www.reportlinker.com/p092577/World-Intranasal-Drug-Delivery-Market.html This report analyzes the US market for Intranasal Drug Delivery in US$ Million. The product is analyzed by the following Therapeutic Areas: Allergic Infections, Analgesics, Osteoporosis, and Vaccinations. Annual forecasts are provided...

2008-09-16 06:00:28

Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent 7,425,542, titled "Stabilizing alkylglycoside compositions and methods thereof." The patent provides broad protection for stabilized human growth hormone (hGH) formulations. Human growth hormone is a recombinant protein drug used in the treatment of pediatric and adult patients who have inadequate secretion of normal endogenous growth hormone. hGH is one of the first biopharmaceuticals to be developed and has...

Word of the Day
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.